Dr. Tinashe Chandauka

Co-Founder and Chief Executive Officer @ TMAB Therapeutics, Inc

About

Dr. Tinashe Chandauka is the CEO and Co-Founder of TMAB Therapeutics, a radiopharmaceutical oncology company built on foundational technology from Memorial Sloan Kettering Cancer Center. He is a repeat biotech founder, physician-scientist, and healthcare/life sciences strategist with experience spanning venture investing, company creation, translational oncology, and public biotech strategy. He is also a Co-Founder, Co-Inventor, and Scientific Advisory Board member of Ethyreal Bio, a Co-Founder and Non-Executive Director of Nandi Life Sciences, and serves as a Healthcare & Life Sciences Executive Strategist for Embarc Collective in Tampa, where he advises founders and emerging companies operating at the intersection of healthcare, biotechnology, and innovation. In 2024, he was selected as a Termeer Fellow, one of the most selective leadership fellowships for first-time biotech CEOs in the United States. Previously, Dr. Chandauka was an Entrepreneur-in-Residence at Texas Medical Center Innovation’s Accelerator for Cancer Therapeutics (ACT), and earlier served as Director of Early Pipeline Development at Tarsus Pharmaceuticals. He began his career at Oxford Science Enterprises, where he supported over $350 million in venture investments, the growth of more than 55 early-stage companies, and the $160 million Series B financing and NASDAQ IPO preparation of Vaccitech. He holds a DPhil from Oxford University as a Rhodes Scholar and a medical degree from the University of Cape Town with distinction and honours. He is licensed to practice medicine in both the United Kingdom and South Africa, and serves on the Board of Directors of Amref Health Africa.

Country

United States

City

Houston

Industry

Biotechnology

Skill

Drug Development, Venture Capital, Business Formation, Business Development, Biotechnology, Clinical Development, Fundraising, Project Management, Medicine, Research, Clinical Research, Public Speaking, Working with Surgeons, Microsoft Office

Experience

Co-Founder and Chief Executive Officer

TMAB Therapeutics, Inc

2023-12 - Present · 2 yrs 10 mos

Houston

• Co-founded TMAB Therapeutics, a biotechnology company focused on delivering DLL3-targeted radiopharmaceuticals from a vertically integrated platform • Led the scientific conception and intellectual property in-licensing from Memorial Sloan Kettering Cancer Center. • Formed a dedicated team and spearheaded all fundraising activities to support our mission of transforming lives through cancer treatment.

Healthcare and Life Sciences Executive Strategist

Embarc Collective

2026-3 - Present · 7 mos

Coach and mentor to high growth life sciences and healthcare executives and founders in the Tampa Bay startup community.

Co-Founder, Co-Inventor and Scientific Advisory Board Member

Ethyreal Bio

2023-10 - Present · 3 yrs

Boston, MA

• Co-founded company and co-invented foundational intellectual property • Contributed to strategy and company build-out across IP generation, scientific positioning, and investor narrative attracting tier-one venture capital Link to launch the company launch: https://www.globenewswire.com/news-release/2026/06/10/3309575/0/en/ethyreal-bio-emerges-from-stealth-with-101-million-in-financing-to-advance-ethy-001-a-potentially-best-in-class-anti-tshr-antibody-for-thyroid-eye-disease-and-graves-disease.html

Co-Founder and NED

Nandi Life Sciences LLC

2023-3 - Present · 3 yrs 7 mos

Houston, TX

I am a Co-Founder and NED of Nandi Life Sciences LLC, my family's biotechnology investment engine and venture studio. Nandi is focused on seeding and incubating oncology and auto-immune biotechnology companies. To date Nandi has incubated and seeded Ethyreal Bio, TMAB with more ventures to come.

Member Board of Trustees

Amref Health Africa UK

2020-8 - Present · 6 yrs 2 mos

London, England Metropolitan Area

Entrepreneur in Residence

Texas Medical Center Innovation Factory

2023-3 - 2024-12 · 1 yr 10 mos

Houston, Texas, United States

Building impactful biotechnology companies with scientists from MD Anderson, UT Health, Baylor and UT Southwestern.

Director, Early Pipeline Development

Tarsus Pharmaceuticals, Inc.

2021-9 - 2023-2 · 1 yr 6 mos

Irvine, California, United States

Board Member

Circadian Therapeutics

2020-2 - 2021-8 · 1 yr 7 mos

Oxford, England, United Kingdom

• Served as a key Board member at Circadian Therapeutics, focusing on scientific strategy and financial stewardship. • Collaborated closely with management to redirect the company after missed R&D milestones. • Successfully led a $2M initiative with a 12-month plan, achieving significant milestones not reached in four years. • Supported initiation of a Phase 1 clinical trial, restoring momentum and strategic clarity for the company.

Investment Associate

Oxford Science Enterprises

2019-9 - 2021-8 · 2 yrs

Oxford, United Kingdom

• Contributed to over $350M in deals, supporting 55 portfolio companies within the Oxford Sciences Innovation framework. • Collaborated with leading Oxford scientists to transform cutting-edge intellectual property into impactful ventures. • Played a key role in the Oxford Vaccine Project, enhancing the university's life-science spinout ecosystem.